BBH
249.45+0.67 +0.27%Past year
Loading chart…
Loading financials…
Company snapshot
- Ticker
- BBH
- Exchange
- NGM
- Currency
- USD
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Latest coverage
- Better Biotechnology ETF: First Trust FBT vs. VanEck BBH
October 10, 2026 - Better Healthcare ETF: VanEck’s Biotech-Focused BBH vs. State Street’s XPH Targeting Pharma
October 10, 2026 - VanEck’s Pharma and Biotech ETFs Take Different Paths to Drug-Sector Exposure
September 15, 2026 - Contrasting Strategies: Broad Healthcare Exposure Versus Focused Biotech Plays
August 5, 2026
Related ETFs & Funds stocks
Global X Robotics & Artificial Intelligence ETFBOTZ
$33.49
iShares Biotechnology ETFIBB
$211.32
iShares Bitcoin Trust ETFIBIT
$47.35
Invesco Nasdaq Biotechnology ETFIBBQ
$35.26